Andrew Christie
Director/Board Member bei HELIOS UNDERWRITING PLC
Vermögen: 78 564 $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Thomas Libassi | M | 66 | 3 Jahre | |
| Ben Mingay | M | 58 |
Smith Square Partners LLP
 Smith Square Partners LLP Investment ManagersFinance Smith Square Partners LLP provides corporate finance advisory services. It offers its services to corporations, private equity firms, investors and entrepreneurs. The firm specializes in public company takeovers, company acquisitions and sales, advising on capital markets transactions, refinancing and restructuring, and management advice. The company was founded by Benjamin Edward Mingay in 2010 and is headquartered in London, the United Kingdom. | 14 Jahre |
| Arthur Manners | M | 65 | 9 Jahre | |
| Nigel Hanbury | M | 67 | 12 Jahre | |
| Paul Waterman | M | 60 | 8 Jahre | |
| Martin Reith | M | 59 | 3 Jahre | |
| Ralph Hewins | M | 61 | 8 Jahre | |
| Dorothée Anna Deuring | F | 55 | 7 Jahre | |
| Michael J. Wade | M | 82 | 1 Jahre | |
| Alexander Phillips | M | 54 |
Smith Square Partners LLP
Smith Square Partners LLP Investment ManagersFinance Smith Square Partners LLP provides corporate finance advisory services. It offers its services to corporations, private equity firms, investors and entrepreneurs. The firm specializes in public company takeovers, company acquisitions and sales, advising on capital markets transactions, refinancing and restructuring, and management advice. The company was founded by Benjamin Edward Mingay in 2010 and is headquartered in London, the United Kingdom. | - |
| Martha Bruce | F | - | 10 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Harold Cunningham | M | 77 | - | |
| Ian Brindle | M | 80 | 9 Jahre | |
| Andrew Duff | M | 65 | 7 Jahre | |
| Brian G. Taylorson | M | 68 | 14 Jahre | |
| Anne Philomena Hyland | F | 64 | 9 Jahre | |
| Wolfgang Plischke | M | 72 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 7 Jahre |
| Steve Good Good | M | 63 | 10 Jahre | |
| Jeremy Evans | M | 66 | 14 Jahre | |
| Robert G. Beeston | M | 82 | 7 Jahre | |
| Edward Fitzalan-Howard | M | 68 | 6 Jahre | |
| David W. Dutro | M | 68 | 18 Jahre | |
| Nick Salmon Salmon | M | 72 | 6 Jahre | |
| David Philip Bloxham | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 4 Jahre |
| Kevin Roger Kenneth Matthews | M | 60 | 9 Jahre | |
| Christopher Girling | M | 70 | 8 Jahre | |
| Sandra Lynne Boss | F | 57 | 3 Jahre | |
| Ken Morris | M | - | - | |
| Ken Smith | M | - | - | |
| Wendi Weber | M | - | 2 Jahre | |
| Robert Sklans | M | - | 2 Jahre | |
| Rob Mangold | M | - | - | |
| Dennis Turner | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 10 Jahre |
| Brad Rector | M | - | - | |
| Russell Banks | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | - |
| David Bowyer | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 7 Jahre |
| Paul Lumbis | M | - | 3 Jahre | |
| James Michael Yorrick Oliver | M | 83 | - | |
| Nigel Richard Parker | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 13 Jahre |
| Mark H. Richmond | M | 93 |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 13 Jahre |
| Iain Ross | M | 71 |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 5 Jahre |
| Greg Bellotti | M | - | 9 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 42 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Andrew Christie
- Persönliches Netzwerk
